Literature DB >> 12368260

Fragile X-related protein and VIG associate with the RNA interference machinery.

Amy A Caudy1, Mike Myers, Gregory J Hannon, Scott M Hammond.   

Abstract

RNA interference (RNAi) is a flexible gene silencing mechanism that responds to double-stranded RNA by suppressing homologous genes. Here, we report the characterization of RNAi effector complexes (RISCs) that contain small interfering RNAs and microRNAs (miRNAs). We identify two putative RNA-binding proteins, the Drosophila homolog of the fragile X mental retardation protein (FMRP), dFXR, and VIG (Vasa intronic gene), through their association with RISC. FMRP, the product of the human fragile X locus, regulates the expression of numerous mRNAs via an unknown mechanism. The possibility that dFXR, and potentially FMRP, use, at least in part, an RNAi-related mechanism for target recognition suggests a potentially important link between RNAi and human disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368260      PMCID: PMC187452          DOI: 10.1101/gad.1025202

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  43 in total

Review 1.  Post-transcriptional gene silencing by double-stranded RNA.

Authors:  S M Hammond; A A Caudy; G J Hannon
Journal:  Nat Rev Genet       Date:  2001-02       Impact factor: 53.242

2.  An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells.

Authors:  S M Hammond; E Bernstein; D Beach; G J Hannon
Journal:  Nature       Date:  2000-03-16       Impact factor: 49.962

3.  A species of small antisense RNA in posttranscriptional gene silencing in plants.

Authors:  A J Hamilton; D C Baulcombe
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

4.  The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation.

Authors:  P H Olsen; V Ambros
Journal:  Dev Biol       Date:  1999-12-15       Impact factor: 3.582

5.  Genetic requirements for inheritance of RNAi in C. elegans.

Authors:  A Grishok; H Tabara; C C Mello
Journal:  Science       Date:  2000-03-31       Impact factor: 47.728

6.  Role for a bidentate ribonuclease in the initiation step of RNA interference.

Authors:  E Bernstein; A A Caudy; S M Hammond; G J Hannon
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

7.  Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein.

Authors:  L Wan; T C Dockendorff; T A Jongens; G Dreyfuss
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

8.  Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the Type-1 plasminogen activator inhibitor mRNA.

Authors:  J H Heaton; W M Dlakic; M Dlakic; T D Gelehrter
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

9.  An extensive class of small RNAs in Caenorhabditis elegans.

Authors:  R C Lee; V Ambros
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

10.  Gemin4. A novel component of the SMN complex that is found in both gems and nucleoli.

Authors:  B Charroux; L Pellizzoni; R A Perkinson; J Yong; A Shevchenko; M Mann; G Dreyfuss
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

View more
  224 in total

1.  The microRNAs of Caenorhabditis elegans.

Authors:  Lee P Lim; Nelson C Lau; Earl G Weinstein; Aliaa Abdelhakim; Soraya Yekta; Matthew W Rhoades; Christopher B Burge; David P Bartel
Journal:  Genes Dev       Date:  2003-04-02       Impact factor: 11.361

2.  Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway.

Authors:  Torgeir Holen; Mohammed Amarzguioui; Eshrat Babaie; Hans Prydz
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

Review 3.  MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.

Authors:  Andrea de Bartolomeis; Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

Review 4.  Evidence demonstrating role of microRNAs in the etiopathology of major depression.

Authors:  Yogesh Dwivedi
Journal:  J Chem Neuroanat       Date:  2011-04-14       Impact factor: 3.052

Review 5.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

6.  Identification of many microRNAs that copurify with polyribosomes in mammalian neurons.

Authors:  John Kim; Anna Krichevsky; Yonatan Grad; Gabriel D Hayes; Kenneth S Kosik; George M Church; Gary Ruvkun
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

Review 7.  RNA interference: biology, mechanism, and applications.

Authors:  Neema Agrawal; P V N Dasaradhi; Asif Mohmmed; Pawan Malhotra; Raj K Bhatnagar; Sunil K Mukherjee
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

8.  Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference.

Authors:  Kumiko Ui-Tei; Yuki Naito; Fumitaka Takahashi; Takeshi Haraguchi; Hiroko Ohki-Hamazaki; Aya Juni; Ryu Ueda; Kaoru Saigo
Journal:  Nucleic Acids Res       Date:  2004-02-09       Impact factor: 16.971

9.  An siRNA ribonucleoprotein is found associated with polyribosomes in Trypanosoma brucei.

Authors:  Appolinaire Djikeng; Huafang Shi; Christian Tschudi; Shuiyuan Shen; Elisabetta Ullu
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

10.  A microRNA array reveals extensive regulation of microRNAs during brain development.

Authors:  Anna M Krichevsky; Kevin S King; Christine P Donahue; Konstantin Khrapko; Kenneth S Kosik
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.